ACE2 and Respiratory tract infection: By single-cell RNA sequencing, nasal goblet and ciliated epithelial cells were shown to have the highest levels of ACE2 expression in vitro as well as the highest infectivity in vivo when compared with other respiratory tracts, thus suggesting that the nasal mucosa may be the dominant initial site for SARS-CoV-2 respiratory tract infection [47].